Correlation Between Mineralys Therapeutics, and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Mineralys Therapeutics, and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Pmv Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Pmv Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mineralys and Pmv is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Pmv Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.57 times more return on investment than Pmv Pharmaceuticals. However, Mineralys Therapeutics, is 1.57 times more volatile than Pmv Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 1,212 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would earn a total of 58.00 from holding Mineralys Therapeutics, Common or generate 4.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Pmv Pharmaceuticals |
Mineralys Therapeutics, and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Pmv Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |